First Deals Signed During Ontario Mission To Middle East
May 24, 2010 4:40 PM
McGuinty Meets Israeli Prime Minister In Visit To Jerusalem
Ontario's life sciences mission celebrated the first new partnerships signed between Israeli and Ontario companies at a ceremony in Tel Aviv.
The partnerships included:
- Axela Inc. is signing a next generation instrument development agreement with Kangaroo Design and Innovation
- Axela Inc. and Kangaroo-Borsuk-Toronto (KBT) are announcing the establishment of a Canadian instrument service depot within the KBT facility in Toronto
- Axela Inc. announced it has signed a MOU with Tarom Applied Technologies Ltd. of Tel Aviv to validate the clinical performance and commercialize Axela's Breast Cancer Prognostic Array in Israel
- Claron Technology and BrainsGate are entering into an agreement to develop a system that would allow experts at a central location to monitor and assist surgeons performing image-guided surgical procedures at many remote locations
- Profound Medical Inc of Ontario and Nanomotion of Israel are signing a MOU to advance innovation and commercialisation for image-guided, minimally -invasive medical devices
- Queen's University, PARTEQ Innovations and Mosaic Crystals are signing an agreement to enhance future research, development and commercialization activities in photovoltaics
- York University and Hebrew University are reaffirming their long-standing relationship (since 1977) and agreement to continue to develop programs in areas of mutual research and academic interest
- Ontario's Ministry of Research and Innovation and Israel's Ministry of Industry, Trade and Labour are pleased to announce that both will make equal contributions toward the continuation of the R and D Agreement signed in 2005
The meeting focused on opportunities to improve trade and build new partnerships between Israel and Ontario. Netanyahu expressed great interest in Ontario's education system and a future meeting of respective education officials is now being planned. Other topics discussed included renewable energy, clean water technology and the potential for collaboration on brain research.
Quick Facts
- Ontario recently launched a $161-million Life Sciences Commercialization Strategy.
- The cost of conducting R&D in Ontario is lower than in most G7 countries, according to data released in the 2010 KPMG Competitive Alternatives Report.
Learn More
- See the 2010 Premier's Summit Award winners in Medical Research.
- Read about Ontario's mission to the Middle East.
Office of the Premier
ontario.ca/premier


